Rachel van Leeuwaarde

Research Staff Other

Strategic program(s):

Contact

rleeuwaa@umcutrecht.nl

Pure profile

Recent publications

All publications

Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endocrine Neoplasia Type 1 Riccardo Ballarò, Amanda R Wasylishen, Carolina R C Pieterman, Courtney Olsen, Ehsan Irajizad, Ranran Wu, Hiroyuki Katayama, Huiling Liu, Yining Cai, Ricardo A León-Letelier, Jennifer B Dennison, Steven Waguespack, Kim-Anh Do, Sunita K Agarwal, Mary Walter, James Welch, Lee Weinstein, Jenny E Blau, Smita Jha, Naris Nilubol, Menno R Vriens, Rachel S van Leeuwaarde, Mark J C van Treijen, Gerlof D Valk, Nancy D Perrier, Samir M Hanash, Johannes F Fahrmann
Cancer Letters, 2025, vol. 614

Sarcomas arising in MEN1 patients Rachel S van Leeuwaarde, Thorvardur R Halfdanarson, Shwetha M Sudhakar, Ruud W J Meijers, Andrew L Folpe, Lodewijk A A Brosens
Familial cancer, 2024, vol. 24

The epidemiology of von Hippel-Lindau disease Rachel S. van Leeuwaarde, Reut Halperin
2024, p.27-41

Expression of integrin α vβ 3 in medullary thyroid carcinoma. Lisa H de Vries, Lutske Lodewijk, Emma W Pijnappel, Paul J van Diest, Abbey Schepers, Han J Bonenkamp, Ilse Ach van Engen-van Grunsven, Schelto Kruijff, Bettien M van Hemel, Thera P Links, Els Jm Nieveen van Dijkum, Susanne van Eeden, Rachel S van Leeuwaarde, Gerlof D Valk, Bart de Keizer, Inne Hm Borel Rinkes, Menno R Vriens
Future Oncology, 2024, vol. 20, p.2015-2022

Somatostatin receptor 2A expression in von Hippel-Lindau-related hemangioblastomas Saya Ahmad, Angelika Muhlebner, Tom J Snijders, Wendy W de Leng, Tatjana Seute, Rachel S van Leeuwaarde
Cancer, 2024, vol. 130, p.3473-3479

Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors Denise S. Hoogenkamp, Linda J. de Wit–van der Veen, Daphne M.V. Huizing, Margot E.T. Tesselaar, Rachel S. van Leeuwaarde, Marcel P.M. Stokkel, Marnix G.E.H. Lam, Arthur J.A.T. Braat
Current Oncology Reports, 2024, vol. 26, p.551-561